Exhibitor Details

Back

PINNACLE LIFE SCIENCES PVT. LTD.

MAHENDRA INDUSTRIAL ESTATE, GROUND FLOOR, PLOT NO. 109-D, ROAD NO. 29, SION (E), MUMBAI 400 022, INDIA
HTTPS://PINNACLELIFESCIENCE.COM/

Product Categories

Formulations
APIXABAN (5 MG),ATORVASTATIN (20 MG),ATORVASTATIN (40 MG),AZITHROMYCIN (500 MG),CELECOXIB (200 MG),CETIRIZINE (10 MG),CIPROFLOXACIN (500 MG),CLOPIDOGREL (75 MG),DICLOFENAC (50 MG),DICLOFENAC (50 MG) + PARACETAMOL (500 MG),ETORICOXIB (90 MG),IBUPROFEN (400 MG),IBUPROFEN (400 MG) + PARACETAMOL (325 MG),METFORMIN (850 MG),NORFLOXACIN (400 MG),OFLOXACIN (200 MG)+ORINDAZOLE (500 MG),OMEPRAZOLE (20 MG),PREGABALIN (75 MG),RIVAROXABAN (20 MG),ROSUVASTATIN (20 MG),ROSUVASTATIN (40 MG),SITAGLIPTIN (100 MG),SITAGLIPTIN (50 MG),SITAGLIPTIN (50 MG) + METFORMIN (1000 MG),SITAGLIPTIN (50 MG) + METFORMIN (850 MG)

Company Profile

PINNACLE LIFE SCIENCE PVT. LTD, LAID ITS FOUNDATION IN 2015 AND IS A 100% SUBSIDIARY OF AARTI DRUGS LTD (ADL) AND FORMS PART O BILLION CONGLOMERATE OF THE ESTEEMED AARTI GROUP OF INDUSTRIES. A LONG COMMITMENT OF 35 YEARS TOWARDS HEALTHCARE THROUGH AARTI DRUGS LTD HAS ENABLED US TO SPREAD OUR WINGS IN ALL DIRECTIONS. WE ARE VERTICALLY INTEGRATED AND SPECIALIZE IN BULK APIS, INTERMEDIATES AND FINISHED FORMULATIONS. AT PINNACLE, WE ARE PROUD OF OUR COMPREHENSIVE PORTFOLIO WITH A STRONG PRESENCE IN BOTH ACUTE AND CHRONIC AILMENT MEDICATION. OUR ANNUAL PRODUCTION CAPACITY IS 3 BILLION TABLETS AND 300 MILLION CAPSULES. WE ARE PARTNERING WITH MORE THAN 250 CLIENTS AND OUR GLOBAL PRESENCE IS IN FRENCH WEST AFRICA, EAST AFRICA, SADC, CENTRAL ASIA AND SOUTH-EAST ASIA, MENA REGION, NORTH AMERICA, CENTRAL AMERICA, LATIN AMERICA (INCLUDING BRAZIL, MEXICO), EUROPE, UK, AUSTRALIA. PINNACLE HAS 2 STATE-OF-THE-ART CGMP-COMPLIANT MANUFACTURING FACILITIES IN INDIA COVERING VARIOUS THERAPEUTIC CATEGORIES.